Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Solitary Fibrous Tumors × Dacarbazine × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 28 Hodgkin Disease 24 Lymphoma 8 Sarcoma 7 Uveal Melanoma 5 Neoplasm Metastasis 4 Neoplasms 2 Leiomyosarcoma 2 Solitary Fibrous Tumors 1 Solid Tumor 1 Skin Neoplasms 1 Sarcoma, Synovial 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Immunotherapy 1 Hyperthermia 1 HIV Infections 1 Carcinoma 1 Advanced Melanoma 1 Acquired Immunodeficiency Syndrome 1 AIDS-Related Complex 1

Interventions

pazopanib 1 eribulin 1 Trabectedin 1 Doxorubicin 1 Dasatinib 1 Dacarbazine 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03023124 2024-12-09

STRADA

Italian Sarcoma Group

Phase 2 Completed

Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡